Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
John D. Campbell. (2017) Self-defense against Bacillus anthracis toxins: Is P-selectin the key?. Virulence 8:7, pages 1059-1061.
Read now
Read now
Leila Rahbarnia, Safar Farajnia, Hossein Babaei, Jafar Majidi, Kamal Veisi, Vahideh Ahmadzadeh & Bahman Akbari. (2017) Evolution of phage display technology: from discovery to application. Journal of Drug Targeting 25:3, pages 216-224.
Read now
Read now
Ejike Nwokoro, Ross Leach, Christine Årdal, Enrico Baraldi, Kellie Ryan & Jens Plahte. (2016) An assessment of the future impact of alternative technologies on antibiotics markets. Journal of Pharmaceutical Policy and Practice 9:1.
Read now
Read now
André Frenzel, Thomas Schirrmann & Michael Hust. (2016) Phage display-derived human antibodies in clinical development and therapy. mAbs 8:7, pages 1177-1194.
Read now
Read now
Articles from other publishers (48)
Susanna Esposito, Gayatri Amirthalingam, Matteo Bassetti, Francesco Blasi, Francesco Giuseppe De Rosa, Natasha B. Halasa, Ivan Hung, Albert Osterhaus, Tina Tan, Juan Pablo Torres, Antonio Vena & Nicola Principi. (2023) Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an update from the World Association of Infectious Diseases and Immunological Disorders and the Italian Society of Antinfective Therapy. Frontiers in Immunology 14.
Crossref
Crossref
Navid J. Ayon. (2023) High-Throughput Screening of Natural Product and Synthetic Molecule Libraries for Antibacterial Drug Discovery. Metabolites 13:5, pages 625.
Crossref
Crossref
Kusum Kharga, Lokender Kumar & Sanjay Kumar Singh Patel. (2023) Recent Advances in Monoclonal Antibody-Based Approaches in the Management of Bacterial Sepsis. Biomedicines 11:3, pages 765.
Crossref
Crossref
Sven Kalbitz, Nils Kellner, Martin Macholz, Jörg Ermisch, Jana Fechner & Christoph Lübbert. (2023) Erkrankungen durch hochpathogene Erreger – Teil 2. Krankenhaushygiene up2date 18:01, pages 37-55.
Crossref
Crossref
Raymond M Slay, Rachel Cook, Katherine Hendricks, David Boucher & Michael Merchlinsky. (2022) Pre- and Postlicensure Animal Efficacy Studies Comparing Anthrax Antitoxins. Clinical Infectious Diseases 75:Supplement_3, pages S441-S450.
Crossref
Crossref
Wenfeng Xu, Lei Peng, Chun Li, Tong Wu, Han Chen, Haiyan Zhang, Hong Yu, Yingchun Ye, Yuchuan Wu, Qing Yuan & Siji Nian. (2022)
A novel fully human recombinant antibody neutralizing α‐hemolysin of
Staphylococcus aureus
. APMIS 130:9, pages 578-589.
Crossref
Crossref
Mohmmad Imran, Mohammad Naiyaz Ahmad, Arunava Dasgupta, Preeti Rana, Nanduri Srinivas & Sidharth Chopra. (2022) Novel approaches for the treatment of infections due to multidrug-resistant bacterial pathogens. Future Medicinal Chemistry 14:15, pages 1133-1148.
Crossref
Crossref
Joana C. Antunes, Inês P. Moreira, Fernanda Gomes, Fernando Cunha, Mariana Henriques & Raúl Fangueiro. (2022) Recent Trends in Protective Textiles against Biological Threats: A Focus on Biological Warfare Agents. Polymers 14:8, pages 1599.
Crossref
Crossref
Ortensia Ilaria Parisi, Fabrizio Francomano, Marco Dattilo, Francesco Patitucci, Sabrina Prete, Fabio Amone & Francesco Puoci. (2022) The Evolution of Molecular Recognition: From Antibodies to Molecularly Imprinted Polymers (MIPs) as Artificial Counterpart. Journal of Functional Biomaterials 13:1, pages 12.
Crossref
Crossref
Sean P. Oosterholt & Oscar Della Pasqua. (2021) Population pharmacokinetics of raxibacumab in healthy adult subjects. British Journal of Clinical Pharmacology 87:12, pages 4718-4725.
Crossref
Crossref
Ciamak Ghazaei. (2021) Anti-virulence Therapy Against Bacterial Infections: Mechanisms of Action and Challenges. Journal of Kermanshah University of Medical Sciences 25:3.
Crossref
Crossref
Kristian Daniel Ralph Roth, Esther Veronika Wenzel, Maximilian Ruschig, Stephan Steinke, Nora Langreder, Philip Alexander Heine, Kai-Thomas Schneider, Rico Ballmann, Viola Fühner, Philipp Kuhn, Thomas Schirrmann, André Frenzel, Stefan Dübel, Maren Schubert, Gustavo Marçal Schmidt Garcia Moreira, Federico Bertoglio, Giulio Russo & Michael Hust. (2021) Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Alice Chateau, Sander E. Van der Verren, Han Remaut & Antonella Fioravanti. (2020) The Bacillus anthracis Cell Envelope: Composition, Physiological Role, and Clinical Relevance. Microorganisms 8:12, pages 1864.
Crossref
Crossref
Sunday Temitope Akinwotu & Oluwaseun Fapohunda. (2020) War against antimicrobial resistance. Journal of Microbiology & Experimentation 8:4, pages 148-154.
Crossref
Crossref
Mohamed A. Alfaleh, Hashem O. Alsaab, Ahmad Bakur Mahmoud, Almohanad A. Alkayyal, Martina L. Jones, Stephen M. Mahler & Anwar M. Hashem. (2020) Phage Display Derived Monoclonal Antibodies: From Bench to Bedside. Frontiers in Immunology 11.
Crossref
Crossref
Vladimir Savransky, Boris Ionin & Joshua Reece. (2020) Current Status and Trends in Prophylaxis and Management of Anthrax Disease. Pathogens 9:5, pages 370.
Crossref
Crossref
Chih-Hung Wang, Yi-Hsien Hsieh, Zachary M. Powers & Cheng-Yen Kao. (2020) Defeating Antibiotic-Resistant Bacteria: Exploring Alternative Therapies for a Post-Antibiotic Era. International Journal of Molecular Sciences 21:3, pages 1061.
Crossref
Crossref
V. V. Firstova, I. G. Shemyakin & I. A. Dyatlov. (2020) Current understanding of Bacillus anthracis toxin molecules organization and approaches for blocking their cytotoxic action. Russian Journal of Infection and Immunity 9:5-6, pages 639-647.
Crossref
Crossref
Paul N. Severin & Phillip A. Jacobson. 2020. Nursing Management of Pediatric Disaster. Nursing Management of Pediatric Disaster
85
197
.
Ryan C. Maves & Catherine M. Berjohn. 2020. Highly Infectious Diseases in Critical Care. Highly Infectious Diseases in Critical Care
97
118
.
Zahra Fakhroueian, Fatemeh Katouzian, Pegah Esmaeilzadeh, Soheila Moradi Bidhendi & Pouriya Esmaeilzadeh. (2019) Enhanced engineered ZnO nanostructures and their antibacterial activity against urinary, gastrointestinal, respiratory and dermal genital infections. Applied Nanoscience 9:8, pages 1759-1773.
Crossref
Crossref
Ana Paula Guedes Frazzon, Michele Bertoni Mann & Jeverson Frazzon. 2019. Antibiotic Drug Resistance. Antibiotic Drug Resistance
477
502
.
Roberto VivasAna Andréa Teixeira BarbosaSilvio Santana DolabelaSona Jain. (2019) Multidrug-Resistant Bacteria and Alternative Methods to Control Them: An Overview. Microbial Drug Resistance 25:6, pages 890-908.
Crossref
Crossref
Hemangi B. Shah, Kenneth Smith, Jonathan D. Wren, Carol F. Webb, Jimmy D. Ballard, Rebecka L. Bourn, Judith A. James & Mark L. Lang. (2019) Insights From Analysis of Human Antigen-Specific Memory B Cell Repertoires. Frontiers in Immunology 9.
Crossref
Crossref
Stephen J. BakerDavid J. PayneRino Rappuoli & Ennio De Gregorio. (2018) Technologies to address antimicrobial resistance. Proceedings of the National Academy of Sciences 115:51, pages 12887-12895.
Crossref
Crossref
Pedro J. Esteves, Joana Abrantes, Hanna-Mari Baldauf, Lbachir BenMohamed, Yuxing Chen, Neil Christensen, Javier González-Gallego, Lorenzo Giacani, Jiafen Hu, Gilla Kaplan, Oliver T. Keppler, Katherine L. Knight, Xiang-Peng Kong, Dennis K. Lanning, Jacques Le Pendu, Ana Lemos de Matos, Jia Liu, Shuying Liu, Ana M. Lopes, Shan Lu, Sheila Lukehart, Yukari C. Manabe, Fabiana Neves, Grant McFadden, Ruimin Pan, Xuwen Peng, Patricia de Sousa-Pereira, Ana Pinheiro, Masmudur Rahman, Natalie Ruvoën-Clouet, Selvakumar Subbian, Maria Jesús Tuñón, Wessel van der Loo, Michael Vaine, Laura E. Via, Shixia Wang & Rose Mage. (2018) The wide utility of rabbits as models of human diseases. Experimental & Molecular Medicine 50:5, pages 1-10.
Crossref
Crossref
Marc Caldwell, Terri Hathcock & Kenny V. Brock. (2017)
Passive protection against anthrax in mice with plasma derived from horses hyper-immunized against
Bacillus anthracis
Sterne strain
. PeerJ 5, pages e3907.
Crossref
Crossref
Dante A. Suffredini, Xizhong Cui, Dharmvir Jaswal, Kenneth E. Remy, Yan Li, Junfeng Sun, Steven B. Solomon, Yvonne Fitz, Mahtab Moayeri, Stephen Leppla & Peter Q. Eichacker. (2017) Anthrax immune globulin improves hemodynamics and survival during B. anthracis toxin-induced shock in canines receiving titrated fluid and vasopressor support. Intensive Care Medicine Experimental 5:1.
Crossref
Crossref
Monika Verma, Nagendra Suryanarayana, Urmil Tuteja, Kulanthaivel Thavachelvam, M.K. Rao, Rakesh Bhargava & Sangeeta Shukla. (2017) Anthrax lethal toxin (LeTx) neutralization by PA domain specific antisera. Toxicon 139, pages 58-65.
Crossref
Crossref
Luciana C. Vitorino & Layara A. Bessa. (2017) Technological Microbiology: Development and Applications. Frontiers in Microbiology 8.
Crossref
Crossref
Breanne M. Head, Ethan Rubinstein & Adrienne F. A. Meyers. (2016) Alternative pre-approved and novel therapies for the treatment of anthrax. BMC Infectious Diseases 16:1.
Crossref
Crossref
Philipp Kuhn, Viola Fühner, Tobias Unkauf, Gustavo Marcal Schmidt Garcia Moreira, André Frenzel, Sebastian Miethe & Michael Hust. (2016) Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display. PROTEOMICS - Clinical Applications 10:9-10, pages 922-948.
Crossref
Crossref
Itai Glinert, Elad Bar-David, Assa Sittner, Shay Weiss, Josef Schlomovitz, Amir Ben-Shmuel, Adva Mechaly, Zeev Altboum, David Kobiler & Haim Levy. (2016) Revisiting the Concept of Targeting Only Bacillus anthracis Toxins as a Treatment for Anthrax. Antimicrobial Agents and Chemotherapy 60:8, pages 4878-4885.
Crossref
Crossref
Zachary T. Cusumano, Roger D. Klein & Scott J. Hultgren. 2016. Virulence Mechanisms of Bacterial Pathogens. Virulence Mechanisms of Bacterial Pathogens
753
795
.
Tucker Maxson & Douglas A. Mitchell. (2016) Targeted treatment for bacterial infections: prospects for pathogen-specific antibiotics coupled with rapid diagnostics. Tetrahedron 72:25, pages 3609-3624.
Crossref
Crossref
Zachary T. Cusumano, Roger D. Klein & Scott J. Hultgren. (2016) Innovative Solutions to Sticky Situations: Antiadhesive Strategies for Treating Bacterial Infections. Microbiology Spectrum 4:2.
Crossref
Crossref
Ana Pinheiro, Fabiana Neves, Ana Lemos de Matos, Joana Abrantes, Wessel van der Loo, Rose Mage & Pedro José Esteves. (2015) An overview of the lagomorph immune system and its genetic diversity. Immunogenetics 68:2, pages 83-107.
Crossref
Crossref
Rose G. Mage, Ana Pinheiro, Ana Lemos de Matos & Pedro J. Esteves. 2016. Encyclopedia of Immunobiology. Encyclopedia of Immunobiology
515
525
.
Tobias Unkauf, Sebastian Miethe, Viola Fühner, Thomas Schirrmann, André Frenzel & Michael Hust. 2016. Protein Targeting Compounds. Protein Targeting Compounds
55
76
.
Brian A. BaldoBrian A. Baldo. 2016. Safety of Biologics Therapy. Safety of Biologics Therapy
141
215
.
Eileen Huang, Satish K. Pillai, William A. Bower, Katherine A. Hendricks, Julie T. Guarnizo, Jamechia D. Hoyle, Susan E. Gorman, Anne E. Boyer, Conrad P. Quinn & Dana Meaney-Delman. (2015)
Antitoxin Treatment of Inhalation Anthrax: A Systematic Review
. Health Security 13:6, pages 365-377.
Crossref
Crossref
Bruce Huang, Tao Xie, David Rotstein, Hui Fang & David Frucht. (2015) Passive Immunotherapy Protects against Enteric Invasion and Lethal Sepsis in a Murine Model of Gastrointestinal Anthrax. Toxins 7:10, pages 3960-3976.
Crossref
Crossref
Valéria Szijártó, Luis M. Guachalla, Zehra C. Visram, Katharina Hartl, Cecília Varga, Irina Mirkina, Jakub Zmajkovic, Adriana Badarau, Gerhild Zauner, Clara Pleban, Zoltán Magyarics, Eszter Nagy & Gábor Nagy. (2015) Bactericidal Monoclonal Antibodies Specific to the Lipopolysaccharide O Antigen from Multidrug-Resistant Escherichia coli Clone ST131-O25b:H4 Elicit Protection in Mice. Antimicrobial Agents and Chemotherapy 59:6, pages 3109-3116.
Crossref
Crossref
Xiangyang Chi, Jianmin Li, Weicen Liu, Xiaolin Wang, Kexin Yin, Ju Liu, Xiaodong Zai, Liangliang Li, Xiaohong Song, Jun Zhang, Xiaopeng Zhang, Ying Yin, Ling Fu, Junjie Xu, Changming Yu & Wei Chen. (2015) Generation and Characterization of Human Monoclonal Antibodies Targeting Anthrax Protective Antigen following Vaccination with a Recombinant Protective Antigen Vaccine. Clinical and Vaccine Immunology 22:5, pages 553-560.
Crossref
Crossref
Ganesh C. Ingavle, Les W.J. Baillie, Yishan Zheng, Elzbieta K. Lis, Irina N. Savina, Carol A. Howell, Sergey V. Mikhalovsky & Susan R. Sandeman. (2015) Affinity binding of antibodies to supermacroporous cryogel adsorbents with immobilized protein A for removal of anthrax toxin protective antigen. Biomaterials 50, pages 140-153.
Crossref
Crossref
Bethany Biron, Katie Beck, David Dyer, Marc Mattix, Nancy Twenhafel & Aysegul Nalca. (2015) Efficacy of ETI-204 Monoclonal Antibody as an Adjunct Therapy in a New Zealand White Rabbit Partial Survival Model for Inhalational Anthrax. Antimicrobial Agents and Chemotherapy 59:4, pages 2206-2214.
Crossref
Crossref
Tobias Unkauf, Sebastian Miethe, Viola Fühner, Thomas Schirrmann, André Frenzel & Michael Hust. 2015. Protein Targeting Compounds. Protein Targeting Compounds
55
76
.
Jay W. HooperRebecca L. BrocatoSteven A. KwilasChristopher D. HammerbeckMatthew D. JosleynMichael RoyalsJohn BallantyneHua WuJin-an JiaoHiroaki MatsushitaEddie J. Sullivan. (2014) DNA vaccine–derived human IgG produced in transchromosomal bovines protect in lethal models of hantavirus pulmonary syndrome. Science Translational Medicine 6:264.
Crossref
Crossref